Interestingly, FLUBVs with dual SAα2,6 and SAα2,3 binding specificities have been linked to greater frequencies of lower respiratory tract symptoms, while the SAα2,6-only binding viruses are generally restricted to upper respiratory tract infections [30]. This evidence concerns the gene SAA2 and Recurrent upper respiratory tract infections.